Results A total of 118,064 biopsies were included in this study. Patient age ranged from 30
to 79 years, and 45% of patients were women. On the basis of our meta-analysis, pain at the …

The kidney biopsy is the gold standard in the diagnosis and management of many diseases.
Since its introduction in the 1950s, advancements have been made in biopsy technique to …

Background: Although the number of patients reaching end-stage kidney disease without a
biopsy-proven diagnosis is increasing, the utility of renal biopsy is still an object of debate …

The process of aging population will inevitably increase age-related comorbidities including
chronic kidney disease (CKD). In light of this demographic transition, the lack of an age …

Renal biopsies are the gold standard for diagnosis, staging, and prognosis of underlying
parenchymal kidney disease. This article provides an overview of the current indications and …

Acute interstitial nephritis (AIN) is an important cause of acute kidney injury (AKI), and its
prevalence in the elderly may be increasing. It is largely unknown whether AIN in the elderly …

Background Although renal biopsy is largely employed, even in old patients with systemic
diseases, few clinical studies have addressed its risk management. We aimed to obtain a …

Diabetes mellitus (DM) and chronic kidney disease (CKD) are common in middle aged and
older adult individuals. DM may accelerate the aging process, and the age-related declines …

Percutaneous kidney biopsy is an integral part of a nephrologist's practice. It has helped to
define nephrology as a subspecialty. When indicated, it is a necessary procedure to help …

OBJECTIVES: To assess the role of transarterial embolization (TAE) and critically appraise
its feasibility and efficacy in the management of non-neoplastic renal hemorrhage …